Operating Expenses Summary of Recordati Industria Chimica e Farmaceutica S.p.A.

Recordati Industria Chimica e Farmaceutica S.p.A.'s latest annual operating expenses in 2023 was 856.85 Million EUR , up 8.15% from previous year.
Recordati Industria Chimica e Farmaceutica S.p.A.'s latest quarterly operating expenses in 2024 Q2 was 236.73 Million EUR , up 4.83% from previous quarter.
Recordati Industria Chimica e Farmaceutica S.p.A. reported a annual operating expenses of 792.26 Million EUR in annual operating expenses 2022, up 22.45% from previous year.
Recordati Industria Chimica e Farmaceutica S.p.A. reported a annual operating expenses of 647.02 Million EUR in annual operating expenses 2021, up 13.89% from previous year.
Recordati Industria Chimica e Farmaceutica S.p.A. reported a quarterly operating expenses of 223.78 Million EUR for 2024 Q1, down -4.97% from previous quarter.
Recordati Industria Chimica e Farmaceutica S.p.A. reported a quarterly operating expenses of 203.79 Million EUR for 2023 Q2, down -3.36% from previous quarter.

Annual Operating Expenses Chart of Recordati Industria Chimica e Farmaceutica S.p.A. (2023 - 2003)

Historical Annual Operating Expenses of Recordati Industria Chimica e Farmaceutica S.p.A. (2023 - 2003)

Year	Operating Expenses	Operating Expenses Growth
2023	856.85 Million EUR	8.15%
2022	792.26 Million EUR	22.45%
2021	647.02 Million EUR	13.89%
2020	568.09 Million EUR	-1.25%
2019	575.26 Million EUR	12.6%
2018	510.91 Million EUR	2.88%
2017	496.63 Million EUR	9.65%
2016	452.92 Million EUR	5.6%
2015	428.92 Million EUR	0.83%
2014	425.38 Million EUR	5.29%
2013	404 Million EUR	14.71%
2012	352.2 Million EUR	4.02%
2011	338.58 Million EUR	1.59%
2010	333.28 Million EUR	-4.69%
2009	349.69 Million EUR	8.36%
2008	322.7 Million EUR	11.05%
2007	290.58 Million EUR	10.14%
2006	263.83 Million EUR	-0.19%
2005	264.32 Million EUR	20.91%
2004	218.6 Million EUR	5.73%
2003	206.75 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	236.73 Million EUR	4.83%
2024 Q1	223.78 Million EUR	-4.97%
2023 Q2	203.79 Million EUR	-3.36%
2023 FY	856.85 Million EUR	8.15%
2023 Q4	235.48 Million EUR	13.93%
2023 Q3	206.69 Million EUR	1.43%
2023 Q1	210.88 Million EUR	-6.19%
2022 Q2	200.74 Million EUR	21.37%
2022 Q3	201.31 Million EUR	0.28%
2022 Q4	224.79 Million EUR	11.66%
2022 FY	792.26 Million EUR	22.45%
2022 Q1	165.4 Million EUR	-8.25%
2021 FY	647.02 Million EUR	13.89%
2021 Q2	158.32 Million EUR	2.24%
2021 Q1	154.86 Million EUR	2.29%
2021 Q4	180.27 Million EUR	17.39%
2021 Q3	153.56 Million EUR	-3.01%
2020 Q2	129.81 Million EUR	-15.24%
2020 Q4	151.4 Million EUR	13.22%
2020 FY	568.09 Million EUR	-1.25%
2020 Q1	153.15 Million EUR	-3.37%
2020 Q3	133.72 Million EUR	3.01%
2019 Q4	158.5 Million EUR	14.42%
2019 Q3	138.52 Million EUR	0.92%
2019 Q2	137.27 Million EUR	-2.62%
2019 FY	575.26 Million EUR	12.6%
2019 Q1	140.96 Million EUR	6.25%
2018 Q4	132.67 Million EUR	11.8%
2018 FY	510.91 Million EUR	2.88%
2018 Q1	135.72 Million EUR	4.99%
2018 Q2	123.83 Million EUR	-8.76%
2018 Q3	118.67 Million EUR	-4.17%
2017 Q4	129.27 Million EUR	9.7%
2017 Q3	117.84 Million EUR	-2.28%
2017 FY	496.63 Million EUR	9.65%
2017 Q2	120.59 Million EUR	-6.46%
2017 Q1	128.92 Million EUR	8.13%
2016 FY	452.92 Million EUR	5.6%
2016 Q4	119.23 Million EUR	13.49%
2016 Q3	105.05 Million EUR	-5.15%
2016 Q2	110.75 Million EUR	-6.04%
2016 Q1	117.88 Million EUR	5.98%
2015 FY	428.92 Million EUR	0.83%
2015 Q2	106.77 Million EUR	-5.69%
2015 Q1	113.22 Million EUR	2.84%
2015 Q4	111.22 Million EUR	13.84%
2015 Q3	97.69 Million EUR	-8.5%
2014 Q3	100.96 Million EUR	-2.51%
2014 Q2	103.56 Million EUR	-6.49%
2014 Q1	110.75 Million EUR	6.76%
2014 FY	425.38 Million EUR	5.29%
2014 Q4	110.09 Million EUR	9.04%
2013 Q2	102.06 Million EUR	-3.31%
2013 Q3	92.63 Million EUR	-9.25%
2013 Q4	103.74 Million EUR	11.99%
2013 FY	404 Million EUR	14.71%
2013 Q1	105.56 Million EUR	27.13%
2012 Q1	93.91 Million EUR	12.21%
2012 Q2	88.35 Million EUR	-5.92%
2012 Q3	86.89 Million EUR	-1.65%
2012 Q4	83.03 Million EUR	-4.44%
2012 FY	352.2 Million EUR	4.02%
2011 FY	338.58 Million EUR	1.59%
2011 Q1	86.6 Million EUR	-1.58%
2011 Q3	75.56 Million EUR	-18.49%
2011 Q4	83.69 Million EUR	10.76%
2011 Q2	92.71 Million EUR	7.05%
2010 Q1	83.08 Million EUR	-10.07%
2010 Q3	74.24 Million EUR	-15.6%
2010 Q4	88 Million EUR	18.53%
2010 FY	333.28 Million EUR	-4.69%
2010 Q2	87.96 Million EUR	5.87%
2009 FY	349.69 Million EUR	8.36%
2009 Q4	92.38 Million EUR	12.98%
2009 Q1	82.89 Million EUR	0.0%
2009 Q2	92.65 Million EUR	11.77%
2009 Q3	81.77 Million EUR	-11.74%
2008 FY	322.7 Million EUR	11.05%
2007 FY	290.58 Million EUR	10.14%
2006 FY	263.83 Million EUR	-0.19%
2005 FY	264.32 Million EUR	20.91%
2004 FY	218.6 Million EUR	5.73%
2003 FY	206.75 Million EUR	0.0%

Peer Operating Expenses Comparison of Recordati Industria Chimica e Farmaceutica S.p.A.

Name	Operating Expenses	Operating Expenses Difference

Global Stocks Search

Recordati Industria Chimica e Farmaceutica S.p.A. (REC.MI)

Operating Expenses Summary of Recordati Industria Chimica e Farmaceutica S.p.A.

Annual Operating Expenses Chart of Recordati Industria Chimica e Farmaceutica S.p.A. (2023 - 2003)

Historical Annual Operating Expenses of Recordati Industria Chimica e Farmaceutica S.p.A. (2023 - 2003)

Peer Operating Expenses Comparison of Recordati Industria Chimica e Farmaceutica S.p.A.